PT2081935T - Polimorfo b de n-{2-fluoro-5-3-(tiofeno-2-carbonil)- pirazolo[1,5-a] pirimidin-7-il]-fenil}-n-metil-acetamida - Google Patents

Polimorfo b de n-{2-fluoro-5-3-(tiofeno-2-carbonil)- pirazolo[1,5-a] pirimidin-7-il]-fenil}-n-metil-acetamida

Info

Publication number
PT2081935T
PT2081935T PT78211646T PT07821164T PT2081935T PT 2081935 T PT2081935 T PT 2081935T PT 78211646 T PT78211646 T PT 78211646T PT 07821164 T PT07821164 T PT 07821164T PT 2081935 T PT2081935 T PT 2081935T
Authority
PT
Portugal
Prior art keywords
polymorph
pyrazolo
pyrimidin
acetamide
thiophene
Prior art date
Application number
PT78211646T
Other languages
English (en)
Inventor
Anglada Luis
Palomer Albert
Guglietta Antonio
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37789824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2081935(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of PT2081935T publication Critical patent/PT2081935T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT78211646T 2006-10-11 2007-10-10 Polimorfo b de n-{2-fluoro-5-3-(tiofeno-2-carbonil)- pirazolo[1,5-a] pirimidin-7-il]-fenil}-n-metil-acetamida PT2081935T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85074306P 2006-10-11 2006-10-11
EP06122138A EP1918290A1 (en) 2006-10-11 2006-10-11 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide

Publications (1)

Publication Number Publication Date
PT2081935T true PT2081935T (pt) 2017-08-29

Family

ID=37789824

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78211646T PT2081935T (pt) 2006-10-11 2007-10-10 Polimorfo b de n-{2-fluoro-5-3-(tiofeno-2-carbonil)- pirazolo[1,5-a] pirimidin-7-il]-fenil}-n-metil-acetamida

Country Status (21)

Country Link
US (2) US8039476B2 (pt)
EP (2) EP1918290A1 (pt)
JP (1) JP5171831B2 (pt)
KR (1) KR101418624B1 (pt)
CN (1) CN101622257B (pt)
AR (1) AR063231A1 (pt)
AU (1) AU2007306319B2 (pt)
BR (1) BRPI0717833A2 (pt)
CA (1) CA2666653C (pt)
CL (1) CL2007002928A1 (pt)
DK (1) DK2081935T3 (pt)
ES (1) ES2637137T3 (pt)
MX (1) MX2009003571A (pt)
NO (1) NO342008B1 (pt)
PL (1) PL2081935T3 (pt)
PT (1) PT2081935T (pt)
RU (1) RU2413729C2 (pt)
SI (1) SI2081935T1 (pt)
TW (1) TWI391392B (pt)
UY (1) UY30637A1 (pt)
WO (1) WO2008043800A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1921079A1 (en) * 2006-11-08 2008-05-14 Ferrer Internacional, S.A. Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
US9209332B2 (en) * 2008-03-31 2015-12-08 Kyocera Corporation Solar cell element and solar cell module
IT1391113B1 (it) * 2008-09-30 2011-11-18 Dipharma Francis Srl Procedimento per la preparazione di azelnidipina cristallina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US399621A (en) * 1889-03-12 Canning-house truck
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
BR0014459A (pt) * 1999-09-02 2002-07-16 Neurocrine Biosciences Inc Polìmeros de n-metil-n- (3-{3-[2-tienilcarbonil]-pirazol-[1,5-"alfa"]-pirimidin-7-il } fenil) acetamida e composições e métodos relacionados aos mesmos
KR101063033B1 (ko) * 2002-08-26 2011-09-07 뉴로크린 바이오사이언시즈 인코퍼레이티드 Ｎ-메틸-Ｎ-(3-(3-[2-티에닐카르보닐]-피라졸-[1,5-α]-피리미딘-7-일)페닐)아세트아미드의 신규한 동질이상체 및 그와 관련된 조성물 및 방법
US7304069B2 (en) * 2004-10-18 2007-12-04 Neurocrine Biosciences, Inc. Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Also Published As

Publication number Publication date
AR063231A1 (es) 2009-01-14
SI2081935T1 (sl) 2017-12-29
NO342008B1 (no) 2018-03-12
KR20090077796A (ko) 2009-07-15
US20110224234A1 (en) 2011-09-15
JP5171831B2 (ja) 2013-03-27
BRPI0717833A2 (pt) 2014-06-10
CL2007002928A1 (es) 2008-05-09
RU2009117716A (ru) 2010-11-20
US8273753B2 (en) 2012-09-25
TW200827360A (en) 2008-07-01
NO20091625L (no) 2009-05-07
AU2007306319A1 (en) 2008-04-17
EP2081935B1 (en) 2017-05-24
RU2413729C2 (ru) 2011-03-10
KR101418624B1 (ko) 2014-07-15
CN101622257B (zh) 2013-03-27
UY30637A1 (es) 2008-05-02
EP1918290A1 (en) 2008-05-07
US8039476B2 (en) 2011-10-18
US20100087451A1 (en) 2010-04-08
TWI391392B (zh) 2013-04-01
AU2007306319B2 (en) 2012-12-06
WO2008043800A1 (en) 2008-04-17
PL2081935T3 (pl) 2018-04-30
EP2081935A1 (en) 2009-07-29
ES2637137T3 (es) 2017-10-11
CA2666653A1 (en) 2008-04-17
DK2081935T3 (en) 2017-09-04
CA2666653C (en) 2014-12-30
MX2009003571A (es) 2009-04-14
CN101622257A (zh) 2010-01-06
JP2010505914A (ja) 2010-02-25

Similar Documents

Publication Publication Date Title
IL194076A (en) Benzo Compounds - [d] - Imidzo [2, 1 – b] Thiazole-2-Ilphenyl for the Treatment of Illness
HK1094800A1 (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino [4,5-c]pyrrole
IL195238A0 (en) Pyrazolo [1,5-a]pyrimidines as cdk inhibitors
SI1740593T1 (sl) Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata
ZA201004368B (en) Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
HK1157652A1 (en) 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines 4--3-()-[34-d]
HRP20130533T1 (en) Amorphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide
EP2034834A4 (en) PRODRUGS OF 5-AMINO-3- (3'-DEOXY-BETA-D-RIBOFURANOSYL) -THIAZOL [4,5-D] PYRIMIDIN-2,7-DION
PT2081935T (pt) Polimorfo b de n-{2-fluoro-5-3-(tiofeno-2-carbonil)- pirazolo[1,5-a] pirimidin-7-il]-fenil}-n-metil-acetamida
ZA200705035B (en) Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity
IL181355A0 (en) Process for producing n-halogenated organic compounds
IL180942A0 (en) Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
EP2436684A4 (en) SALTS OF METHYL (R) -7- [3-AMINO-4- (2,4,5-TRIFLUOR-PHENYL) -BUTYRYL] -3-TRIFLUOROMETHYL-5,6,7,8-TETRAHYDRO-IMIDAZO- [1, 5-A] pYRAZINE-1-carboxylate
IL177856A0 (en) 2-pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
GB0402262D0 (en) Process for the manufacture of organic compounds
PT1937662E (pt) Processo para a preparação de duloxetina
IL198689A0 (en) Pyrrolo [1,2-a] imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotheraupeutic agents
PL2086978T3 (pl) Bezpostaciowa forma N-{2-fluoro-5-[3-(tiofeno-2-karbonylo)pirazolo[1,5- A]pirymidyn-7-ylo]fenylo-N-metyloacetamidu
SI2059521T1 (sl) Pirazolo alfa pirimidini postopki uporabe in sestavki
MX2009003567A (es) Procedimiento para la fabricacion de un compuesto cristalino de pirazolo[1,5-a]prirmidina.
ZA201105439B (en) 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives
HUP0501046A2 (en) Process for the preparation of olanzapine
IL189370A0 (en) PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE COMPOUND
HUP0400325A3 (en) Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates